CHEMOTHERAPY OF GASTRIC-CANCER

被引：74

作者：

PREUSSER, P

ACHTERRATH, W

WILKE, H

LENAZ, L

FINK, U

HEINICKE, A

MEYER, J

BUNTE, H

机构：

[1] UNIV CLIN MUENSTER, DEPT SURG, MED ONCOL SECT, MUENSTER, FED REP GER

[2] UNIV MUNSTER, INST MED INFORMAT & BIOMATH, D-4400 MUNSTER, FED REP GER

[3] TECH UNIV MUNICH, MED CLIN, D-8000 MUNICH 2, FED REP GER

[4] MED SCH HANNOVER, DEPT HEMATOL ONCOL, HANNOVER, FED REP GER

来源：

CANCER TREATMENT REVIEWS | 1988年 / 15卷 / 04期

关键词：

D O I：

10.1016/0305-7372(88)90025-4

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：257 / 277

页数：21

共 139 条

[1]

AABO K, 1985, CANCER TREAT REP, V69, P449

[2]

AHLGREN JD, 1984, P AN M AM SOC CLIN, V145, pC565

[3] A PHASE-I TRIAL OF CONTINUOUS INFUSION VP16-213 (ETOPOSIDE) [J].

AISNER, J ;

VANECHO, DA ;

WHITACRE, M ;

WIERNIK, PH .

CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1982, 7 (2-3) :157-160

[4] A PHASE-II TRIAL OF 5-FLUOROURACIL AND HIGH-DOSE INTRAVENOUS LEUCOVORIN IN GASTRIC-CARCINOMA [J].

ARBUCK, SG ;

DOUGLASS, HO ;

TRAVE, F ;

MILLIRON, S ;

BARONI, M ;

NAVA, H ;

EMRICH, LJ ;

RUSTUM, YM .

JOURNAL OF CLINICAL ONCOLOGY, 1987, 5 (08) :1150-1156

[5]

ASAKAWA H, 1973, Journal of Japan Society for Cancer Therapy, V8, P362

[6]

ASAKAWA H, 1971, NIPPON ACTA RADIOL, V31, P505

[7]

BAKER LH, 1976, CANCER TREAT REP, V60, P733

[8] THE NATURAL-HISTORY OF GASTRIC-CANCER AND PROGNOSTIC FACTORS INFLUENCING SURVIVAL [J].

BEDIKIAN, AY ;

CHEN, TT ;

KHANKHANIAN, N ;

HEILBRUN, LK ;

MCBRIDE, CM ;

MCMURTREY, MJ ;

BODEY, GP .

JOURNAL OF CLINICAL ONCOLOGY, 1984, 2 (04) :305-310

[9] A PHASE-II STUDY OF CISPLATIN IN ADVANCED GASTRIC-CANCER [J].

BEER, M ;

COCCONI, G ;

CECI, G ;

VARINI, M ;

CAVALLI, F .

EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1983, 19 (06) :717-720

[10]

BENGMARK S, 1982, LIVER METASTASES, P268

← 1 2 3 4 5 6 7 8 9 10 →